PD 131628 is an antimicrobial agent and active PD 131112 metabolite. PD 131628 is two- to four-fold more active than Ciprofloxacin ( HY-B0356 ), inhibiting all strains of Staphylococcus aureus and Streptococcus pneumoniae . PD 131628 is very active against Neisseria spp., Haemophilus influenzae and Moraxella catarrhalis , with MIC 90 s ranging from 0.004 to 0.008 mg/L.
Products | Products > Disease Areas > Infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > Drug Metabolite | Products > Signaling Pathways > Bacterial
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.